McAlpine, J. N., Wiegand, K. C., Vang, R., Ronnett, B. M., Adamiak, A., Köbel, M., . . . Miller, D. M. (2009). HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy. BioMed Central.
Chicago ZitierstilMcAlpine, Jessica N., et al. HER2 Overexpression and Amplification Is Present in a Subset of Ovarian Mucinous Carcinomas and Can Be Targeted With Trastuzumab Therapy. BioMed Central, 2009.
MLA ZitierstilMcAlpine, Jessica N., et al. HER2 Overexpression and Amplification Is Present in a Subset of Ovarian Mucinous Carcinomas and Can Be Targeted With Trastuzumab Therapy. BioMed Central, 2009.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.